HomeHealth

Health

Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study

Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study

September 26, 2022

Centene Subsidiary Selected to Continue Serving Nebraska’s Medicaid Managed Care Members

Centene Subsidiary Selected to Continue Serving Nebraska’s Medicaid Managed Care Members

September 26, 2022

HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference

HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference

September 26, 2022

WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

September 26, 2022

Bionano Genomics Announces Launch of CLIA-Certified Bionano Laboratories, and Expands its Clinical Testing Menu with Launch of First OGM-Based LDT for FSHD

Bionano Genomics Announces Launch of CLIA-Certified Bionano Laboratories, and Expands its Clinical Testing Menu with Launch of First OGM-Based LDT for FSHD

September 23, 2022

Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe

Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe

September 23, 2022

Henry Ford Health First in Michigan to Offer Multi-Cancer Early Detection Blood Test

Henry Ford Health First in Michigan to Offer Multi-Cancer Early Detection Blood Test

September 23, 2022

ReShape Lifesciences(TM) Awarded Phase I NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation(TM) Device

ReShape Lifesciences(TM) Awarded Phase I NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation(TM) Device

September 23, 2022

GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr

GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr

September 22, 2022

iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

September 22, 2022

« 1 … 220 221 222 223 224 … 246 »